We conclude that separating the ABC-DLBCL subset according to relative expression of the two IRF4 cofactors SPIB and BATF identifies subgroups differentially linked to previously defined features of DLBCL tumour biology. This evidence concerns the gene IRF4 and diffuse large B-cell lymphoma.